Advancing Social Connection Through Social Prescribing: A Translational and Implementation Science Perspective
Abstract
Social disconnection, encompassing loneliness and social isolation, is a major determinant of health associated with increased morbidity, mortality, and healthcare utilization. Although healthcare systems increasingly screen for social risks, a translational gap persists between identification and intervention. Social prescribing, defined as the referral of patients to non-medical, community-based resources, offers a promising approach to bridge this gap; however, its integration into healthcare systems remains fragmented and insufficiently grounded in translational science. This paper presents a narrative review and conceptual synthesis of social prescribing, integrating empirical evidence with implementation and translational science frameworks, including the National Center for Advancing Translational Sciences Translational Spectrum. Evidence suggests potential psychosocial benefits, but findings are heterogeneous, and questions remain regarding standardization, scalability, and alignment with clinical workflows. Social prescribing frequently stalls between clinical recognition (T2) and implementation (T3), limiting population-level impact. Ethical concerns may arise when screening occurs in the absence of accessible intervention pathways, particularly in resource-constrained settings where unmet need is acute. This paper proposes a translational framework situating social prescribing across the T2–T4 spectrum, linking screening, referral infrastructure, and community integration within a feedback-informed model. Advancing social prescribing as a scalable and equitable component of healthcare will require rigorous effectiveness–implementation research, cross-sector collaboration, and supportive policy environments.
Related
- Social prescribing for anxiety and depression in older adults: mechanistic pathways, implementation requirements, and limitations of current evidence
- Advancing the Translational Pipeline: From In Vivo and In Vitro 2D Models to Next-Generation Cell Culture Models for Amyotrophic Lateral Sclerosis Modelling and Drug Discovery
- Advancing regenerative biomaterials and translational strategies in orthopaedic traumatology.
- Wellbeing While Waiting: Effectiveness and implementation of youth social prescribing for young people awaiting CAMHS support
- Nonlinear effects of built environment on metro-feeder bike-sharing as a dynamic green exposure pathway: a dual perspective of connection frequency and modal share
BibTeX
@article{alisonwarrenphdc2026advancing,
title = {{Advancing Social Connection Through Social Prescribing: A Translational and Implementation Science Perspective}},
author = {Alison Warren PhDc, DAOM, MSHS, Dip. ABLM, Dip. ABAAHP},
journal = {Inquiry: The Journal of Health Care Organization, Provision, and Financing},
year = {2026},
month = nov,
doi = {10.1177/00469580261506186},
url = {https://doi.org/10.1177/00469580261506186},
note = {CC BY},
}
RIS
TY - JOUR
TI - Advancing Social Connection Through Social Prescribing: A Translational and Implementation Science Perspective
AU - Alison Warren PhDc, DAOM, MSHS, Dip. ABLM, Dip. ABAAHP
PY - 2026
DA - 2026/11/04
JO - Inquiry: The Journal of Health Care Organization, Provision, and Financing
DO - 10.1177/00469580261506186
UR - https://doi.org/10.1177/00469580261506186
AB - Social disconnection, encompassing loneliness and social isolation, is a major determinant of health associated with increased morbidity, mortality, and healthcare utilization. Although healthcare systems increasingly screen for social risks, a translational gap persists between identification and intervention. Social prescribing, defined as the referral of patients to non-medical, community-based resources, offers a promising approach to bridge this gap; however, its integration into healthcare systems remains fragmented and insufficiently grounded in translational science. This paper presents a narrative review and conceptual synthesis of social prescribing, integrating empirical evidence with implementation and translational science frameworks, including the National Center for Advancing Translational Sciences Translational Spectrum. Evidence suggests potential psychosocial benefits, but findings are heterogeneous, and questions remain regarding standardization, scalability, and alignment with clinical workflows. Social prescribing frequently stalls between clinical recognition (T2) and implementation (T3), limiting population-level impact. Ethical concerns may arise when screening occurs in the absence of accessible intervention pathways, particularly in resource-constrained settings where unmet need is acute. This paper proposes a translational framework situating social prescribing across the T2–T4 spectrum, linking screening, referral infrastructure, and community integration within a feedback-informed model. Advancing social prescribing as a scalable and equitable component of healthcare will require rigorous effectiveness–implementation research, cross-sector collaboration, and supportive policy environments.
SN - 1945-7243
SN - 0046-9580
ER -